Evidence map›Paper›PMID 36431344›Full record

ArticleJournal of clinical medicine2022

Sufentanil vs. Dexmedetomidine as Neuraxial Adjuvants in Cesarean Section: A Mono-Centric Retrospective Comparative Study.

Antonio Coviello, Carmine Iacovazzo, Anella D'Abrunzo, Marilena Ianniello, Maria Grazia Frigo, Annachiara Marra, Pasquale Buonanno, Maria Silvia Barone, Giuseppe Servillo, Maria Vargas

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Antonio CovielloDepartment of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", 80100 Naples, Italy.ORCID 0000-0002-2298-566X
Carmine IacovazzoDepartment of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", 80100 Naples, Italy.
Anella D'AbrunzoDepartment of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", 80100 Naples, Italy.
Marilena IannielloDepartment of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", 80100 Naples, Italy.ORCID 0000-0001-9336-5807
Maria Grazia FrigoDepartment of Anesthesia and Resuscitation in Obstetrics, San Giovanni Calibita Fatebenefratelli Hospital, 39, 00186 Rome, Italy.
Annachiara MarraDepartment of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", 80100 Naples, Italy.
Pasquale BuonannoDepartment of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", 80100 Naples, Italy.
Maria Silvia BaroneDepartment of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", 80100 Naples, Italy.
Giuseppe ServilloDepartment of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", 80100 Naples, Italy.
Maria VargasDepartment of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples "Federico II", 80100 Naples, Italy.ORCID 0000-0001-7652-970X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal anesthesia is the best choice for caesarean delivery. This technique is characterized by a complete and predictable nerve block with a fast onset and few complications. Several intrathecal adjuvants are used in order to improve the quality and duration of anesthesia and reduce its side effects. Sixty-two patients who underwent caesarean delivery under spinal anesthesia were included in this medical records review. In this retrospective study, after adopting exclusion criteria, we assessed 24 patients who received Hyperbaric Bupivacaine 0.5% 10 mg and dexmedetomidine 10 μg (G1), and 28 patients who received an institutional standard treatment with Hyperbaric Bupivacaine 0.5% 10 mg and sufentanil 5 μg (G2). We evaluated the difference in terms of motor and sensory block, postoperative pain, and adverse effects during the first 24 h following delivery and neonatal outcome. Our study found that the sufentanil group had a significantly lower requirement for analgesia than the dexmedetomidine group. Postoperative pain, assessed with the VAS scale, was stronger in G1 than in G2 (4 ± 2 vs. 2 ± 1, p-value < 0.01). Differences between the two groups regarding the intraoperative degree of motor and sensory block, motor recovery time, and neonatal Apgar scores were not noticed. Pruritus and shivering were observed only in G2. Itching and shivering did not occur in the dexmedetomidine group. Postoperative analgesia was superior in the sufentanil group, but the incidence of side effects was higher. Adjuvant dexmedetomidine prevented postoperative shivering.

Indexed as

caesarean deliverydexmedetomidineintrathecalintrathecal sufentanilpostoperative painspinal anesthesia

Identifiers

PMID36431344
PMCPMC9694597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.